Peter J. Quinn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Peter J. Quinn has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Claude Wolf
APLIPID Sarl, Appl Lipid Invest, F-75116 Paris, France
8 shared publicationsXiaoyuan Wang
State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu Province, China
4 shared publicationsAntonin Lamaziere
Sorbonne Universités - UPMC Univ Paris 06, INSERM ERL , 1157, CNRS UMR 7203 LBM, CHU Saint-Antoine 27 rue de Chaligny, F-75012, Paris , France
2 shared publicationsCedric Tessier
2 shared publications- Claude Wolf
Applied Lipidomics Investigation, APLIPID Sarl
2 shared publications Dominique Rainteau
2 shared publications
Latest Publications
- 29 March 2018
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 102 (10) , 4319-4330
Production of l-valine from metabolically engineered Corynebacterium glutamicum
L-Valine is one of the three branched-chain amino acids (valine, leucine, and isoleucine) essential for animal health and important in metabolism; therefore, it is widely added in the products of food, medicine, and feed. l-Valine is predominantly produced through microbial fermentation, and the production efficiency largely depends on the quality of microorganisms. In recent years, continuing efforts have been made in revealing the mechanisms and regulation of l-valine biosynthesis in Corynebacterium glutamicum, the most utilitarian bacterium for amino acid production. Metabolic engineering based on the metabolic biosynthesis and regulation of l-valine provides an effective alternative to the traditional breeding for strain development. Industrially competitive l-valine-producing C. glutamicum strains have been constructed by genetically defined metabolic engineering. This article reviews the global metabolic and regulatory networks responsible for l-valine biosynthesis, the molecular mechanisms of regulation, and the strategies employed in C. glutamicum strain engineering.
- 29 March 2018
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 102 (10) , 4319-4330
Production of l-valine from metabolically engineered Corynebacterium glutamicum
L-Valine is one of the three branched-chain amino acids (valine, leucine, and isoleucine) essential for animal health and important in metabolism; therefore, it is widely added in the products of food, medicine, and feed. l-Valine is predominantly produced through microbial fermentation, and the production efficiency largely depends on the quality of microorganisms. In recent years, continuing efforts have been made in revealing the mechanisms and regulation of l-valine biosynthesis in Corynebacterium glutamicum, the most utilitarian bacterium for amino acid production. Metabolic engineering based on the metabolic biosynthesis and regulation of l-valine provides an effective alternative to the traditional breeding for strain development. Industrially competitive l-valine-producing C. glutamicum strains have been constructed by genetically defined metabolic engineering. This article reviews the global metabolic and regulatory networks responsible for l-valine biosynthesis, the molecular mechanisms of regulation, and the strategies employed in C. glutamicum strain engineering.
- 1 July 2014
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1838 (7) , 1922-1930
Sphingolipid symmetry governs membrane lipid raft structure
- 1 July 2014
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1838 (7) , 1922-1930
Sphingolipid symmetry governs membrane lipid raft structure
- 12 May 2014
- Published by Taylor & Francis in Expert Opinion on Drug Discovery
- Vol. 9 (7) , 819-836
How lipidomics provides new insight into drug discovery
Introduction: Automated lipidomic methods based on mass spectrometry (MS) are now proposed to screen a large variety of candidate drugs available that inhibit de novo lipid synthesis and replace tedious methods based on radiotracer incorporation. A major new interest in inhibitors of de novo lipogenesis is their proapoptotic effect observed in cancerous cells. Areas covered: In this review, the authors focus on the screening methods of antilipogenic inhibitors targeting the synthesis of malonylCoA (carbonic anhydrase, acetylCoA carboxylase), palmitylCoA (fatty acid synthase condensing and thioesterase subunits) and monounsaturated fatty acids (D9-desaturase). The consequences of inhibition depend on how the pathway deviates above the blockade: accelerated mitochondrial fatty acid oxidation following the decreased malonylCoA level, accumulation of ketone bodies and increased cholesterol synthesis following the increased acetylCoA level. Side effects such as anorexia and skin defects may critically decrease therapeutic indices in the long term. The authors emphasize the need for assessment of toxicity in short-term treatments inducing proapoptotic effects observed in aggressive hormone-dependent malignancies. Expert opinion: The activity of lipogenesis inhibitors can be recognised in lipid profiles established by a combination of MS-based measurements and multivariate analysis processing hundreds of lipid molecular species. Because the method can be automated, it is suitable for screening large chemical libraries, with particular focus on anticancer activities.
- 12 May 2014
- Published by Taylor & Francis in Expert Opinion on Drug Discovery
- Vol. 9 (7) , 819-836
How lipidomics provides new insight into drug discovery
Introduction: Automated lipidomic methods based on mass spectrometry (MS) are now proposed to screen a large variety of candidate drugs available that inhibit de novo lipid synthesis and replace tedious methods based on radiotracer incorporation. A major new interest in inhibitors of de novo lipogenesis is their proapoptotic effect observed in cancerous cells. Areas covered: In this review, the authors focus on the screening methods of antilipogenic inhibitors targeting the synthesis of malonylCoA (carbonic anhydrase, acetylCoA carboxylase), palmitylCoA (fatty acid synthase condensing and thioesterase subunits) and monounsaturated fatty acids (D9-desaturase). The consequences of inhibition depend on how the pathway deviates above the blockade: accelerated mitochondrial fatty acid oxidation following the decreased malonylCoA level, accumulation of ketone bodies and increased cholesterol synthesis following the increased acetylCoA level. Side effects such as anorexia and skin defects may critically decrease therapeutic indices in the long term. The authors emphasize the need for assessment of toxicity in short-term treatments inducing proapoptotic effects observed in aggressive hormone-dependent malignancies. Expert opinion: The activity of lipogenesis inhibitors can be recognised in lipid profiles established by a combination of MS-based measurements and multivariate analysis processing hundreds of lipid molecular species. Because the method can be automated, it is suitable for screening large chemical libraries, with particular focus on anticancer activities.
- 17 July 2013
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 29 (30) , 9447-9456
Structure of Sphingomyelin Bilayers and Complexes with Cholesterol Forming Membrane Rafts
Sphingomyelin and cholesterol are of interest to biologists because they interact to form condensed structures said to be responsible for a variety of functions that membranes perform. Synchrotron X-ray diffraction methods have been used to investigate the structure of bilayers of d-erythro palmitoyl-sphingomyelin and complexes formed by palmitoyl- and egg-sphingomyelin with cholesterol in aqueous multibilayer dispersions. d-erythro palmitoyl sphingomyelin bilayers exist in two conformers that are distinguished by their lamellar repeat spacing, bilayer thickness, and polar group hydration. The distinction is attributed to hydrogen bonding to water or to intermolecular hydrogen bonds that are disrupted by the formation of ripple structure. The coexisting bilayer structures of pure palmitoyl sphingomyelin are observed in the presence of cholesterol-rich bilayers that are characterized by different bilayer parameters. The presence of cholesterol preferentially affects the conformer of d-erythro sphingomyelin with thicker, more hydrated bilayers. Coexisting bilayers of sphingomyelin and complexes with cholesterol are in register and remain coupled at temperatures at least up to 50 °C. Cholesterol forms a complex of 1.8 mols of sphingomyelin per cholesterol at 37 °C that coexists with bilayers of pure sphingomyelin up to 50 °C. Redistribution of the two lipids takes place on cooling below the fluid- to gel-phase transition temperature, resulting in the withdrawal of sphingomyelin into gel phase and the formation of coexisting bilayers of equimolar proportions of the two lipids. Cholesterol-rich bilayers fit a stripe model at temperatures less than 37 °C characterized by alternating rows of sphingomyelin and cholesterol molecules. A quasicrystalline array models the arrangement at higher temperatures in which each cholesterol molecule is surrounded by seven hydrocarbon chains, each of which is in contact with two cholesterol molecules. The thickness of bilayer complexes of sphingomyelin and cholesterol is less than that of coexisting bilayers of pure sphingomyelin. The implications for protein sorting theories based on bilayer thickness are discussed.
- 17 July 2013
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 29 (30) , 9447-9456
Structure of Sphingomyelin Bilayers and Complexes with Cholesterol Forming Membrane Rafts
Sphingomyelin and cholesterol are of interest to biologists because they interact to form condensed structures said to be responsible for a variety of functions that membranes perform. Synchrotron X-ray diffraction methods have been used to investigate the structure of bilayers of d-erythro palmitoyl-sphingomyelin and complexes formed by palmitoyl- and egg-sphingomyelin with cholesterol in aqueous multibilayer dispersions. d-erythro palmitoyl sphingomyelin bilayers exist in two conformers that are distinguished by their lamellar repeat spacing, bilayer thickness, and polar group hydration. The distinction is attributed to hydrogen bonding to water or to intermolecular hydrogen bonds that are disrupted by the formation of ripple structure. The coexisting bilayer structures of pure palmitoyl sphingomyelin are observed in the presence of cholesterol-rich bilayers that are characterized by different bilayer parameters. The presence of cholesterol preferentially affects the conformer of d-erythro sphingomyelin with thicker, more hydrated bilayers. Coexisting bilayers of sphingomyelin and complexes with cholesterol are in register and remain coupled at temperatures at least up to 50 °C. Cholesterol forms a complex of 1.8 mols of sphingomyelin per cholesterol at 37 °C that coexists with bilayers of pure sphingomyelin up to 50 °C. Redistribution of the two lipids takes place on cooling below the fluid- to gel-phase transition temperature, resulting in the withdrawal of sphingomyelin into gel phase and the formation of coexisting bilayers of equimolar proportions of the two lipids. Cholesterol-rich bilayers fit a stripe model at temperatures less than 37 °C characterized by alternating rows of sphingomyelin and cholesterol molecules. A quasicrystalline array models the arrangement at higher temperatures in which each cholesterol molecule is surrounded by seven hydrocarbon chains, each of which is in contact with two cholesterol molecules. The thickness of bilayer complexes of sphingomyelin and cholesterol is less than that of coexisting bilayers of pure sphingomyelin. The implications for protein sorting theories based on bilayer thickness are discussed.
- 22 March 2013
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 57 (8) , 1401-1409
The deficit of lipid in cultured cells contrasted with clinical lipidomics
Cells grown in culture are frequently employed to model lipid metabolism in vivo. There are reasons of convenience for this but examination of the lipidome of cultured cells and their metabolic responses to lipid supplementation give cause to indicate disparity with their counterparts in living animals. The reason is mainly that homeostatic regulation is exercised in animals supplied with an adequate diet in which the adipose tissue and liver represent plentiful sources of lipid integrated via inter‐organ collaboration and able to buffer transient fluctuations in dietary lipid and essential fatty acids (EFAs). Moreover, conventional culture media are generally deficient in total lipids as well as essential EFAs. Cultured cells exposed to high glucose concentrations and lipid deficit typically manifest accelerated rates of lipogenesis evidenced by high rates of de novo FA biosynthesis. A more realistic model may be obtained by increasing supplements of lipid especially enriched in essential EFAs in the growth medium. Increasing concentrations of ω3 FAs, in particular, attenuate the rate of de novo lipogenesis. The improvement of cell culture models for pharmacological screening of drug‐candidates targeting lipid or glucose metabolism is highlighted.
- 22 March 2013
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 57 (8) , 1401-1409
The deficit of lipid in cultured cells contrasted with clinical lipidomics
Cells grown in culture are frequently employed to model lipid metabolism in vivo. There are reasons of convenience for this but examination of the lipidome of cultured cells and their metabolic responses to lipid supplementation give cause to indicate disparity with their counterparts in living animals. The reason is mainly that homeostatic regulation is exercised in animals supplied with an adequate diet in which the adipose tissue and liver represent plentiful sources of lipid integrated via inter‐organ collaboration and able to buffer transient fluctuations in dietary lipid and essential fatty acids (EFAs). Moreover, conventional culture media are generally deficient in total lipids as well as essential EFAs. Cultured cells exposed to high glucose concentrations and lipid deficit typically manifest accelerated rates of lipogenesis evidenced by high rates of de novo FA biosynthesis. A more realistic model may be obtained by increasing supplements of lipid especially enriched in essential EFAs in the growth medium. Increasing concentrations of ω3 FAs, in particular, attenuate the rate of de novo lipogenesis. The improvement of cell culture models for pharmacological screening of drug‐candidates targeting lipid or glucose metabolism is highlighted.
- 1 June 2012
- Published by Elsevier in Journal of Controlled Release
- Vol. 160 (2) , 158-163
The effect of tocopherol on the structure and permeability of phosphatidylcholine liposomes
- 1 June 2012
- Published by Elsevier in Journal of Controlled Release
- Vol. 160 (2) , 158-163
The effect of tocopherol on the structure and permeability of phosphatidylcholine liposomes
- Open Access
- 4 January 2012
- Published by MDPI AG in Metabolites
- Vol. 2 (1) , 1-18
Perturbations of Lipid Metabolism Indexed by Lipidomic Biomarkers
The lipidome of the liver and the secreted circulating lipoproteins can now be interrogated conveniently by automated mass spectrometric methods. Multivariate analysis of the liver and serum lipid composition in various animal modes or in human patients has pointed to specific molecular species markers. The perturbations of lipid metabolism can be categorized on the basis of three basic pathological mechanisms: (1) an accelerated rate of de novo lipogenesis; (2) perturbation of the peroxisome pathway of ether-lipid and very-long-chain fatty acid biosynthesis; (3) a change in the rate of interconversion of essential omega-3 and -6 polyunsaturated fatty acids. This review provides examples to illustrate the practicalities of lipidomic studies in biomedicine.
- 4 January 2012
- Published by MDPI AG in Metabolites
- Vol. 2 (1) , 1-18
Open AccessPerturbations of Lipid Metabolism Indexed by Lipidomic Biomarkers
The lipidome of the liver and the secreted circulating lipoproteins can now be interrogated conveniently by automated mass spectrometric methods. Multivariate analysis of the liver and serum lipid composition in various animal modes or in human patients has pointed to specific molecular species markers. The perturbations of lipid metabolism can be categorized on the basis of three basic pathological mechanisms: (1) an accelerated rate of de novo lipogenesis; (2) perturbation of the peroxisome pathway of ether-lipid and very-long-chain fatty acid biosynthesis; (3) a change in the rate of interconversion of essential omega-3 and -6 polyunsaturated fatty acids. This review provides examples to illustrate the practicalities of lipidomic studies in biomedicine.
- 1 December 2011
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1808 (12) , 2894-2904
The structure of complexes between phosphatidylethanolamine and glucosylceramide: A matrix for membrane rafts
- 1 December 2011
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1808 (12) , 2894-2904
The structure of complexes between phosphatidylethanolamine and glucosylceramide: A matrix for membrane rafts
- Open Access
- 27 July 2011
- Published by Wiley in The FEBS Journal
- Vol. 278 (18) , 3518-3527
A synchrotron X-ray diffraction characterization of the structure of complexes formed between sphingomyelin and cerebroside
- 27 July 2011
- Published by Wiley in The FEBS Journal
- Vol. 278 (18) , 3518-3527
Open AccessA synchrotron X-ray diffraction characterization of the structure of complexes formed between sphingomyelin and cerebroside